Discovery of 3-acetyl-4-hydroxy-2-pyranone derivatives and their difluoridoborate complexes as a novel class of HIV-1 integrase Inhibitors
摘要:
HIV-1 integrase (IN) has emerged as an important therapeutic target for anti-HIV drug development. Its uniqueness to the virus and its critical role in the viral life cycle makes IN suitable for selective inhibition. The recent approval of Raltegravir (MK-0518) has created a surge in interest and great optimism in the field. In our ongoing IN drug design research, we herein report the discovery of substituted analogs of 3-acetyl-4-hydroxy-2-pyranones and their difluoridoborate complexes as novel IN inhibitors. In many of these compounds, complexation with boron difluoride increased the potency and selectivity of IN inhibition. Compound 9 was most active with an IC50 value of 9 mu M and 3 mu M for 3'-processing and strand transfer inhibition, respectively. (C) 2008 Elsevier Ltd. All rights reserved.
A series of dehydroaceticacid difluoroboron complexes functionalized by a phenyl ring or an electroactive core (tetrathiafulvalene or ferrocene) were synthesized and characterized. The redox properties of these derivatives have been analyzed by cyclic voltammetry and the molecular structures of some of the difluoroboron complexes are presented and discussed. The photophysical properties of selected
Synthesis and reactions of dehydracetic acid difluoroborane complex
作者:A. V. Manaev、K. V. Tambov、V. F. Traven’
DOI:10.1134/s107042800807018x
日期:2008.7
Dehydracetic acid difluoroborane complex, 3-acetyl-6-methyl-2-oxo-2H-pyran-4-yl difluoridoborate, was synthesized and characterized. The complex was involved into condensation reactions at the acetyl group with various aromatic and heterocyclic aldehydes, and with the 4-dimethylaminobenzaldehyde it reacted also at the methyl group in the position 6.